Vivo Opportunity Fund Holdings, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Regulus Therapeutics Inc. Common Stock, $0.001 par value (RGLS)

Filing Manager: Vivo Opportunity Fund Holdings, L.P.
Reporting Manager: Vivo Opportunity Fund Holdings, L.P.
Security: Regulus Therapeutics Inc. Common Stock, $0.001 par value
Symbol: RGLS
Shares outstanding: 69.1M shares
Disclosed Ownership: 2.7M shares
Ownership: 3.9%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 08:35:13 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vivo Opportunity Fund Holdings, L.P.	3.9%	2.7M	2.7M	0	/s/ Kevin Dai	Kevin Dai/Managing Member
Vivo Opportunity, LLC	3.9%	2.7M	2.7M	0	/s/ Kevin Dai	Kevin Dai/Managing Member